Sivik Global Healthcare LLC
13F Reported Value
ⓘ$131.7M
Holdings
34
Latest Filing
2026-06-30
Filing Quarter
Q2 2026
Portfolio Overview
Sivik Global Healthcare LLC disclosed 34 positions worth $131.7M in its Form 13F-HR for Q2 2026, followed by $CAH. The portfolio is most concentrated in Healthcare (55.0% of disclosed assets). All figures are sourced directly from Sivik Global Healthcare LLC’s Form 13F-HR filing with the SEC under CIK 1596452.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q2 2026
Click any card to unlockTop Holdings
STATE STREET SPDR S&P BIOTECH - S&P BIOTECH
—Quality
$19.2M150,000 sh- 62.4#713
Quality
$5.1M24,000 sh CALL- BSX 100 @ 75 EXP 04/17/2026 - CALL
—Quality
$5.0M800 sh- 69.0
Quality
$4.9M20,000 sh - 59.9
Quality
$4.8M40,000 sh - 61.1
Quality
$4.7M15,000 sh - 87.5
Quality
$4.6M5,000 sh - 60.4
Quality
$4.5M15,000 sh - 75.4
Quality
$4.5M10,000 sh - 79.9
Quality
$4.1M9,000 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
| STATE STREET SPDR S&P BIOTECH - S&P BIOTECH | — | $19.2M | 150,000 |
 CARDINAL HEALTH INC$CAH | 62.4#713 | $5.1M | 24,000 |
| CALL- BSX 100 @ 75 EXP 04/17/2026 - CALL | — | $5.0M | 800 |
 JOHNSON & JOHNSON$JNJ | 69.0 | $4.9M | 20,000 |
 Merck & Co., Inc.$MRK | 59.9 | $4.8M | 40,000 |
 Cencora, Inc.$COR | 61.1 | $4.7M | 15,000 |
 ELI LILLY & Co$LLY | 87.5 | $4.6M | 5,000 |
 WATERS CORP /DE/$WAT | 60.4 | $4.5M | 15,000 |
 VERTEX PHARMACEUTICALS INC / MA$VRTX | 75.4 | $4.5M | 10,000 |
 INTUITIVE SURGICAL INC$ISRG | 79.9 | $4.1M | 9,000 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Sivik Global Healthcare LLC's 34 positions.
Showing top 10 of 34 holdings.
Sector Allocation
Healthcare
$72.4M
Other
$24.2M
Technology
$21.9M
Consumer Staples
$13.2M
Full Holdings — Sivik Global Healthcare LLC (Q2 2026)
All 34 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | — | STATE STREET SPDR S&P BIOTECH - S&P BIOTECH | $19.2M | 14.6% | +0% | — |
| 2 | $CAH | CARDINAL HEALTH INC | $5.1M | 3.9% | +0% | 62.4 |
| 3 | — | CALL- BSX 100 @ 75 EXP 04/17/2026 - CALL | $5.0M | 3.8% | +0% | — |
| 4 | $JNJ | JOHNSON & JOHNSON | $4.9M | 3.7% | +0% | 69 |
| 5 | $MRK | Merck & Co., Inc. | $4.8M | 3.6% | +0% | 59.9 |
| 6 | $COR | Cencora, Inc. | $4.7M | 3.6% | +0% | 61.1 |
| 7 | $LLY | ELI LILLY & Co | $4.6M | 3.5% | +0% | 87.5 |
| 8 | $WAT | WATERS CORP /DE/ | $4.5M | 3.4% | +0% | 60.4 |
| 9 | $VRTX | VERTEX PHARMACEUTICALS INC / MA | $4.5M | 3.4% | +0% | 75.4 |
| 10 | $ISRG | INTUITIVE SURGICAL INC | $4.1M | 3.1% | +0% | 79.9 |
| 11 |  $AZN | ASTRAZENECA PLC | $3.9M | 3.0% | +0% | — |
| 12 |  $TMO | THERMO FISHER SCIENTIFIC INC. | $3.9M | 3.0% | +0% | 65.1 |
| 13 |  $BSX | BOSTON SCIENTIFIC CORP | $3.9M | 3.0% | +0% | 77.5 |
| 14 |  $DHR | DANAHER CORP /DE/ | $3.8M | 2.9% | +0% | 64.8 |
| 15 |  $THC | TENET HEALTHCARE CORP | $3.8M | 2.9% | +0% | 66.2 |
| 16 |  $GILD | GILEAD SCIENCES, INC. | $3.5M | 2.6% | +0% | 57.4 |
| 17 |  $MTD | METTLER TOLEDO INTERNATIONAL INC/ | $3.5M | 2.6% | +0% | 67.5 |
| 18 |  $HUM | HUMANA INC | $3.5M | 2.6% | +0% | 58.9 |
| 19 |  $MCK | MCKESSON CORP | $3.5M | 2.6% | +0% | 63.4 |
| 20 |  $A | AGILENT TECHNOLOGIES, INC. | $3.4M | 2.6% | +0% | 67.1 |
| 21 |  $SYK | STRYKER CORP | $3.3M | 2.5% | +0% | 72.1 |
| 22 |  $ABBV | AbbVie Inc. | $3.3M | 2.5% | +0% | 72.6 |
| 23 |  $UHS | UNIVERSAL HEALTH SERVICES INC | $3.1M | 2.4% | +0% | 66.7 |
| 24 |  $REGN | REGENERON PHARMACEUTICALS, INC. | $3.1M | 2.4% | +0% | 71 |
| 25 |  $BIO | BIO-RAD LABORATORIES, INC. | $2.8M | 2.1% | +0% | 48.9 |
| 26 |  $BIIB | BIOGEN INC. | $2.8M | 2.1% | +0% | 64.7 |
| 27 |  $UNH | UNITEDHEALTH GROUP INC | $2.7M | 2.0% | +0% | 62.7 |
| 28 |  $GMED | GLOBUS MEDICAL INC | $2.6M | 2.0% | +0% | 79.5 |
| 29 |  $ABT | ABBOTT LABORATORIES | $2.6M | 1.9% | +0% | 65.5 |
| 30 |  $EW | Edwards Lifesciences Corp | $1.6M | 1.2% | +0% | 69.4 |
| 31 |  $SNN | SMITH & NEPHEW PLC | $1.6M | 1.2% | +0% | — |
| 32 |  $ELV | Elevance Health, Inc. | $1.5M | 1.1% | +0% | 59 |
| 33 |  $EHC | Encompass Health Corp | $1.5M | 1.1% | +0% | 66.9 |
| 34 |  $CVS | CVS HEALTH Corp | $1.4M | 1.1% | +0% | 59.4 |
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Sivik Global Healthcare LLC including:
Track Sivik Global Healthcare LLC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Sivik Global Healthcare LLC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Sivik Global Healthcare LLC
13F Pro is an AI hedge fund tracker and stock research platform. For Sivik Global Healthcare LLC (SEC CIK: 1596452), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Sivik Global Healthcare LLC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.